Segment & Geographic Data
Quant-Grade Normalized (live API)
API & CSV Delivery
Viewray Inc's Business Segments
Viewray Inc's reported revenue by business segment and by geographic region, quarterly and annual, normalized against the consolidated income statement. Free below: the top 3 rows per table, this quarter and this fiscal year. Subscriber access adds the full segment history and operating income by segment.
Segment Data As of FY
Reportable Segments
-
Largest Segment
-
Total Revenue
-
Regions Reported
1
Viewray Inc does not report a distinct business-segment axis in its filings - its disaggregated revenue is disclosed by product and service category instead. See the Product & Service breakdown below.
Revenue Share by Region - FY
- Non-US79.4%
Revenue by Geographic Region - FY
| Region | Revenue (Millions) | % of Total |
|---|---|---|
| Non-US | $ 18 | 79.4% |
Revenue by Product & Service Category - FY
- Product70%
- Service28.9%
- Distribution Service1%
Revenue by Product & Service Category - FY
| Category | Revenue (Millions) | % of Total |
|---|---|---|
| Product | $ 16 | 70% |
| Service | $ 7 | 28.9% |
| Distribution Service | $ 0 | 1% |
Product and service categories are a supplemental disclosure and are not required to sum to consolidated revenue or to the reportable segments above.
Description of Viewray Inc
Viewray Inc is a publicly traded medical technology company headquartered in Cleveland, Ohio. The company designs and manufactures advanced radiation therapy systems for the treatment of cancer. Viewray's patented technology utilizes magnetic resonance imaging (MRI) to guide radiation therapy, resulting in more accurate and precise treatment.
Viewray's flagship product is the MRIdian system, which combines an MRI scanner with a linear accelerator (linac) to provide real-time imaging during radiation therapy delivery. This allows clinicians to monitor the tumor and surrounding tissues in real-time, and adapt the treatment plan as necessary to account for any changes in the patient's anatomy or tumor size.
The MRIdian system has several unique features that set it apart from traditional radiation therapy systems. One of these is the ability to deliver radiation dose while the patient is in motion, which is particularly important for treating tumors in organs such as the lungs or liver that move as the patient breathes. Another is the ability to adjust the radiation beam continuously during treatment, an approach known as adaptive radiation therapy.
Viewray's technology has numerous advantages over traditional radiation therapy systems. For one, it allows for higher doses of radiation to be delivered to the tumor while minimizing damage to healthy tissues. This can improve outcomes for patients with certain types of cancer, such as prostate cancer. Additionally, because the MRIdian system uses MRI for imaging, it does not expose patients to ionizing radiation, which is a concern with other imaging modalities such as CT.
Viewray has a large and growing customer base, with installations of the MRIdian system in cancer centers throughout the world. The company has partnerships with several leading cancer institutions, including MD Anderson Cancer Center and the Mayo Clinic. Viewray's revenue has been steadily increasing, and the company is poised for continued growth as it expands its offerings and enters new markets.
Viewray's flagship product is the MRIdian system, which combines an MRI scanner with a linear accelerator (linac) to provide real-time imaging during radiation therapy delivery. This allows clinicians to monitor the tumor and surrounding tissues in real-time, and adapt the treatment plan as necessary to account for any changes in the patient's anatomy or tumor size.
The MRIdian system has several unique features that set it apart from traditional radiation therapy systems. One of these is the ability to deliver radiation dose while the patient is in motion, which is particularly important for treating tumors in organs such as the lungs or liver that move as the patient breathes. Another is the ability to adjust the radiation beam continuously during treatment, an approach known as adaptive radiation therapy.
Viewray's technology has numerous advantages over traditional radiation therapy systems. For one, it allows for higher doses of radiation to be delivered to the tumor while minimizing damage to healthy tissues. This can improve outcomes for patients with certain types of cancer, such as prostate cancer. Additionally, because the MRIdian system uses MRI for imaging, it does not expose patients to ionizing radiation, which is a concern with other imaging modalities such as CT.
Viewray has a large and growing customer base, with installations of the MRIdian system in cancer centers throughout the world. The company has partnerships with several leading cancer institutions, including MD Anderson Cancer Center and the Mayo Clinic. Viewray's revenue has been steadily increasing, and the company is poised for continued growth as it expands its offerings and enters new markets.
ViewRay Inc. is a pioneering medical technology company that specializes in the development of advanced solutions in radiation therapy, particularly focused on enhancing the treatment of cancer. The companys offerings are segmented into two primary categories: Products and Services, each designed to improve the precision and efficacy of treatment for patients with cancer.
Segments
ViewRay operates in the medical technology sector, with a specific emphasis on radiation oncology. This segment is driven by a commitment to harnessing cutting-edge technology to advance cancer treatment methodologies. The companys approach not only seeks to improve clinical outcomes but also aims to enhance the overall patient experience during treatment. ViewRays operations are structured around two major segments:
1. Products: This segment encompasses a variety of sophisticated medical devices and software solutions that aid in the diagnosis and treatment of cancer through radiation therapy.
2. Services: This segment includes comprehensive support solutions that facilitate the implementation, training, and clinical usage of ViewRay’s products to ensure optimal operational performance.
Products
ViewRay’s product lineup features groundbreaking technologies that are transforming the landscape of radiation therapy. The flagship and other notable products include:
1. MRIdian:
- Overview: MRIdian is recognized as ViewRays flagship product and is a revolutionary MRI-guided radiation therapy system.
- Technology: It integrates advanced magnetic resonance imaging (MRI) with real-time radiation therapy, which allows radiation oncologists to visualize tumors and adjacent tissues during treatment. This capability facilitates more accurate targeting of tumor cells while sparing healthy tissue.
- Advantages: The real-time imaging capability allows adjustments to be made dynamically, improving the precision of radiation delivery and minimizing side effects for patients.
2. Stereotactic Ablative Radiotherapy (SABR):
- Overview: SABR is a specialized form of radiation therapy used for delivering high doses of radiation to specific areas of cancerous tissues with remarkable accuracy.
- Technology: Utilizing advanced imaging modalities, SABR enables oncologists to focus intensely on the tumor, allowing for higher doses in fewer treatment sessions.
- Advantages: This approach enhances patient convenience and can lead to better treatment outcomes due to the sparing of surrounding healthy tissue.
3. Treatment Planning Software:
- Overview: ViewRay offers advanced treatment planning systems to streamline the process of creating individualized radiation therapy plans.
- Technology: The software utilizes sophisticated algorithms that analyze complete patient data, which aids in crafting tailored treatment regimens specific to each patients condition and anatomical considerations.
- Advantages: The personalized approach improves overall therapy effectiveness and can enhance patient outcomes.
Services
In addition to its innovative products, ViewRay provides an array of services to ensure successful implementation and effective use of its technologies:
1. Installation and Maintenance:
- Overview: ViewRay provides comprehensive installation and maintenance services for its advanced systems, ensuring that healthcare facilities can operate at peak efficiency.
- Support Team: A network of certified engineers and technicians assist in the setup and ongoing maintenance of the MRIdian systems and other products.
- Advantages: Ongoing maintenance ensures that the systems operate seamlessly, minimizing downtime and enhancing the reliability of cancer treatment delivery.
2. Training and Support:
- Overview: The company emphasizes education through comprehensive training programs tailored for healthcare providers.
- Training Scope: Radiation oncologists, medical physicists, and clinical staff receive detailed instruction on how to effectively utilize ViewRays technologies.
- Advantages: This training enhances the confidence and capabilities of healthcare teams, ultimately leading to better patient care and utilization of the systems.
3. Clinical Support Services:
- Overview: ViewRay’s clinical applications team offers robust support to healthcare facilities in the development of patient-specific treatment plans.
- Collaboration: The team works closely with medical professionals to translate advanced technology into practical applications, ensuring that the treatment is optimized based on individual patient needs.
- Advantages: This collaborative effort fosters a tailored approach to radiation therapy, leading to improved patient outcomes and satisfaction.
Conclusion
ViewRay Inc. is at the forefront of advancing cancer treatment through its innovative products and dedicated services. The MRIdian and SABR systems embody the companys commitment to precision in radiation therapy, while its comprehensive support services ensure that healthcare providers can implement and utilize these technologies effectively. By integrating advanced imaging capabilities with robust clinical support, ViewRay is significantly enhancing the standards of care in radiation oncology and improving the overall experience for patients undergoing cancer treatment.
Segments
ViewRay operates in the medical technology sector, with a specific emphasis on radiation oncology. This segment is driven by a commitment to harnessing cutting-edge technology to advance cancer treatment methodologies. The companys approach not only seeks to improve clinical outcomes but also aims to enhance the overall patient experience during treatment. ViewRays operations are structured around two major segments:
1. Products: This segment encompasses a variety of sophisticated medical devices and software solutions that aid in the diagnosis and treatment of cancer through radiation therapy.
2. Services: This segment includes comprehensive support solutions that facilitate the implementation, training, and clinical usage of ViewRay’s products to ensure optimal operational performance.
Products
ViewRay’s product lineup features groundbreaking technologies that are transforming the landscape of radiation therapy. The flagship and other notable products include:
1. MRIdian:
- Overview: MRIdian is recognized as ViewRays flagship product and is a revolutionary MRI-guided radiation therapy system.
- Technology: It integrates advanced magnetic resonance imaging (MRI) with real-time radiation therapy, which allows radiation oncologists to visualize tumors and adjacent tissues during treatment. This capability facilitates more accurate targeting of tumor cells while sparing healthy tissue.
- Advantages: The real-time imaging capability allows adjustments to be made dynamically, improving the precision of radiation delivery and minimizing side effects for patients.
2. Stereotactic Ablative Radiotherapy (SABR):
- Overview: SABR is a specialized form of radiation therapy used for delivering high doses of radiation to specific areas of cancerous tissues with remarkable accuracy.
- Technology: Utilizing advanced imaging modalities, SABR enables oncologists to focus intensely on the tumor, allowing for higher doses in fewer treatment sessions.
- Advantages: This approach enhances patient convenience and can lead to better treatment outcomes due to the sparing of surrounding healthy tissue.
3. Treatment Planning Software:
- Overview: ViewRay offers advanced treatment planning systems to streamline the process of creating individualized radiation therapy plans.
- Technology: The software utilizes sophisticated algorithms that analyze complete patient data, which aids in crafting tailored treatment regimens specific to each patients condition and anatomical considerations.
- Advantages: The personalized approach improves overall therapy effectiveness and can enhance patient outcomes.
Services
In addition to its innovative products, ViewRay provides an array of services to ensure successful implementation and effective use of its technologies:
1. Installation and Maintenance:
- Overview: ViewRay provides comprehensive installation and maintenance services for its advanced systems, ensuring that healthcare facilities can operate at peak efficiency.
- Support Team: A network of certified engineers and technicians assist in the setup and ongoing maintenance of the MRIdian systems and other products.
- Advantages: Ongoing maintenance ensures that the systems operate seamlessly, minimizing downtime and enhancing the reliability of cancer treatment delivery.
2. Training and Support:
- Overview: The company emphasizes education through comprehensive training programs tailored for healthcare providers.
- Training Scope: Radiation oncologists, medical physicists, and clinical staff receive detailed instruction on how to effectively utilize ViewRays technologies.
- Advantages: This training enhances the confidence and capabilities of healthcare teams, ultimately leading to better patient care and utilization of the systems.
3. Clinical Support Services:
- Overview: ViewRay’s clinical applications team offers robust support to healthcare facilities in the development of patient-specific treatment plans.
- Collaboration: The team works closely with medical professionals to translate advanced technology into practical applications, ensuring that the treatment is optimized based on individual patient needs.
- Advantages: This collaborative effort fosters a tailored approach to radiation therapy, leading to improved patient outcomes and satisfaction.
Conclusion
ViewRay Inc. is at the forefront of advancing cancer treatment through its innovative products and dedicated services. The MRIdian and SABR systems embody the companys commitment to precision in radiation therapy, while its comprehensive support services ensure that healthcare providers can implement and utilize these technologies effectively. By integrating advanced imaging capabilities with robust clinical support, ViewRay is significantly enhancing the standards of care in radiation oncology and improving the overall experience for patients undergoing cancer treatment.